You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

January 15, 2021

Hemp Now Legally Permitted for Use in Cosmetics in Thailand

Subscribe to Updates

Following the recent delisting of almost all parts of the hemp plant from Thailand’s list of prohibited narcotics (see here for further details), the Ministry of Public Health has issued a notification allowing hemp to be used in cosmetics. Prior to this development, this use of hemp (whether from natural or synthetic sources) was not allowed, as it fell under the definition of narcotics under the Notification Re: Ingredients Not Allowed for Use in Cosmetics B.E. 2559 (2016).

Under the Ministerial Notification Re: Use of Hemp in Cosmetics B.E. 2564 (2021), which was published in the Government Gazette on January 11, 2021, domestic manufacturers are now allowed to produce cosmetics containing hemp seed oil or hemp seed extract, provided the cosmetics do not have a THC level exceeding 0.2% by weight.

To register such products with the Thai FDA, applicants must submit a certificate of analysis, safety data sheet, and label for the agency’s evaluation. The timeline for approval of the registration (notification) of a cosmetic containing hemp seed oil or hemp seed extract is three business days. The applicant (i.e., manufacturer or toll manufacturer) must declare the amount of hemp seed extract or hemp seed oil used in the cosmetic in their notification application. Cosmetics must not use a name for the product that evokes an association with hemp flowers or narcotics, and the name of the product must be within the scope of cosmetics. For example, names containing “inflorescence,” “flower,” “CBD,” “THC” or similar will not be allowed.

It should also be noted that Thailand does not yet allow the importation of cosmetics containing hemp seeds or hemp seed extract, and this regulation only applies to domestically produced hemp products—a business currently restricted to individuals or companies with Thai nationality.

For more details on this development, or on any aspect of hemp and cannabis regulations in Thailand, please contact Tilleke & Gibbins at [email protected].

Related Professionals

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

April 30, 2011
Recent years have witnessed a proliferation in the number of products available under the “nutritional food” heading. For companies to stand out from their competitors in this growing sector, marketing and advertising is integral for success. The ability to make claims regarding products is a significant aspect of this process. While the number of products has been on the rise, there has also been an augmentation in demand among consumers for healthier, more nutritious products. This, coupled with more aggressive advertising tactics, could lead to exaggerated or egregious claims.
Read More
April 30, 2011
As most ASEAN Food and Drug Administrations and Ministries of Agriculture labor under critical backlogs of product registration applications for the growing number of products being released into Asian markets, businesses are looking to new ways to facilitate approvals. Outsourcing product registration work to law firms is becoming an increasingly popular way for regulatory affairs departments to speed up applications as local knowledge and effective navigation go a long way in Asia.
Read More
April 30, 2011
Recent scandals, particularly the one involving melamine-tainted milk from China, have impacted consumer awareness in a big way, making consumers pay more attention to the quality and safety of the products they purchase. This is particularly true for products that are ingested, such as food and beverages. In Thailand, these products must first receive approval from the Food and Drug Administration in the case of food and drugs, and the Excise Department in the case of alcoholic beverages, before launching in the market.
Read More
April 30, 2011
Recently, the members of Association of Southeast Asian Nations (ASEAN) attempted to improve product registration efficiency and marketing approval for pharmaceutical products. The ASEAN harmonization regime hopes to improve the standard of the Food and Drug Administrations’ (FDAs) regulatory reviews in ASEAN countries. Despite these efforts, however, the lingering obstacle of a lack of intellectual property understanding continues to leave pharmaceutical companies with difficulties when dealing with product registration in several ASEAN FDAs.
Read More